tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (PL:RVU)
:RVU
Poland Market

Ryvu Therapeutics SA (RVU) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Ryvu Therapeutics SA’s (RVU) Moving Averages Convergence Divergence (MACD) indicator is -0.41, suggesting Ryvu Therapeutics SA is a Buy.
Ryvu Therapeutics SA’s (RVU) 20-Day exponential moving average is 25.78, while Ryvu Therapeutics SA’s (RVU) share price is zł27.65, making it a Sell.
Ryvu Therapeutics SA’s (RVU) 50-Day exponential moving average is 26.21, while Ryvu Therapeutics SA’s (RVU) share price is zł27.65, making it a Sell.

Ryvu Therapeutics SA (RVU) Pivot Points

Feb 15, 2026, 04:12 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.13
24.52
25.03
25.42
25.93
26.32
26.83
Fibonacci
24.52
24.86
25.07
25.42
25.76
25.97
26.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ryvu Therapeutics SA (RVU) Moving Averages

Feb 15, 2026, 04:12 AM
Period
Simple
Exponential
MA5
25.41Sell
25.34Sell
MA10
25.21Sell
25.45Sell
MA20
25.88Sell
25.78Sell
MA50
26.42Sell
26.21Sell
MA100
26.21Sell
26.57Sell
MA200
28.25Sell
27.32Sell
Ryvu Therapeutics SA’s (RVU) 10-Day exponential moving average is 25.45, while Ryvu Therapeutics SA’s (RVU) share price is zł27.65, making it a Sell.
Ryvu Therapeutics SA’s (RVU) 100-Day exponential moving average is 26.57, while Ryvu Therapeutics SA’s (RVU) share price is zł27.65, making it a Sell.
Ryvu Therapeutics SA’s (RVU) stock price is zł27.65 and Ryvu Therapeutics SA’s (RVU) 50-day simple moving average is 26.42, creating a Sell signal.
Ryvu Therapeutics SA’s (RVU) stock price is zł27.65 and Ryvu Therapeutics SA’s (RVU) 100-day simple moving average is 26.21, creating a Sell signal.
Ryvu Therapeutics SA’s (RVU) stock price is zł27.65 and Ryvu Therapeutics SA’s (RVU) 200-day simple moving average is 28.25, creating a Sell signal.

Ryvu Therapeutics SA (RVU) Technical Indicators

Feb 15, 2026, 04:12 AM
Name
Value
Implied Action
RSI (14)
42.23
Neutral
STOCH (9,6)
70.79
Neutral
STOCHRSI (14)
44.44
Neutral
MACD (12,26)
-0.41
Buy
ADX (14)
10.64
Buy
Williams %R
-65.15
Buy
CCI (14)
-58.40
Neutral
ATR (14)
0.91
-
Ultimate Oscillator
57.68
Neutral
ROC
-4.91
Sell
Ryvu Therapeutics SA’s (RVU) Relative Strength Index (RSI) is 42.23, creating a Neutral signal.
Ryvu Therapeutics SA’s (RVU) Trend Strength Indicator (ADX) is 10.64, creating a Buy signal.
Ryvu Therapeutics SA’s (RVU) Commodity Channel Index (CCI) is -58.40, creating a Neutral signal.
Ryvu Therapeutics SA’s (RVU) Price Rate of Change (ROC) is -4.91, creating a Sell signal.

FAQ

Is RVU a Buy, Hold, or Sell?
Based on RVU’s technical indicators, RVU is a Strong Sell.
    What is RVU’s RSI (14)?
    RVU’s RSI (14) is 42.23, which suggests RVU is a Neutral.
      What is RVU’s MACD?
      RVU’s MACD is -0.41, which suggests RVU is a Buy.
        What is RVU’s 5-day moving average?
        RVU’s 5-day moving average is 25.41, which suggests RVU is a Sell.
          What is RVU’s 20-day moving average?
          RVU 20-day moving average is 25.88, which suggests RVU is a Sell.
            What is RVU’s 50-day moving average?
            RVU’s 50-day moving average is 26.42, which suggests RVU is a Sell.
              What is RVU’s 200-day moving average?
              RVU’s 200-day moving average is 28.25, which suggests RVU is a Sell.
                What is RVU’s Williams % R (14)?
                RVU’s Williams % R (14) is -65.15, which suggests RVU is a Buy.
                  What is RVU’s CCI (14)?
                  RVU’s CCI (14) is -58.40, which suggests RVU is a Neutral.
                    What is the share price of Ryvu Therapeutics SA?